IP Verse

Genentech vs. Celltrion - UPC_CFI_166/2024

The UPC Case UPC_CFI_166/2024 was filed on 09 Apr, 2024 by the plaintiff Genentech, Novartis against the defendant Celltrion.

Case Details

    Case Number:

    UPC_CFI_166/2024

    Patent Number:

    EP3805248

    Filing Date:

    09 Apr, 2024

    Proceeding Type:

    Provisionalmeasures

    Case Phase:

    Case Closed

    Plaintiffs:

    • Genentech
    • Novartis

    Plaintiff Representatives:

    • Kilian SEIDEL

    Defendants:

    • Celltrion

    Defendant Representatives:

    • Emilia ZALEWSKA

    Judges:

    • Alima Zana
    • Berenice Thom
    • John Petersen
    • Ronny Thomas

Case Decision

Decision pending - set alert to receive updates

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

DateTitleLink
Mar 27, 2025Case Closure Formal Check-
Sep 6, 2024Measures Decisionoutcome Notification-
Sep 6, 2024Headnote And Keywords-
Sep 6, 2024Final Order On Pi Application
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S04-
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S03-
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S02-
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S01-
Sep 3, 2024Submission Of Epo Preliminary Opinion-
Sep 3, 2024Receipt-
Sep 3, 2024Exhibit Fbd 46-
Jul 24, 2024Time Limits For Parties' Oral Submissions
Jun 27, 2024Rejoinder Upc Celltrion V Novartis (Signed)-
Jun 27, 2024Bb49 Expert Declaration Dr. L. De Leede Of 26 June-
Jun 27, 2024Bb49B Annexes To Expert Declaration Dr. L. De Leede Of 26 June-
Jun 27, 2024Bb49A Cv Of Dr. L. De Leede-
Jun 27, 2024Bb48 Notice From The Epo Regarding Accelerated Proceedings Of 17 June-
Jun 27, 2024Bb47 Presta Et Al J Immunol 1993 VOL 151 No 5 P 2623 2632-
Jun 27, 2024Bb46 Cacia Et Al Biochemistry 1996 VOL 35 No 6 P 1897 1903-
Jun 27, 2024Bb45 Expert Declaration Prof. Dr. T. Dingermann Of 26 June-
Jun 27, 2024Bb45B Annexes To Expert Declaration Of Prof. Dr. T. Dingermann-
Jun 27, 2024Bb45A Cv Of Prof. Dr. T. Dingermann-
Jun 27, 2024Bb44 Expert Declaration Prof. Dr. H.W. Frijlink Of 26 June (Expert Declaration Of Prof. Dr. H.W. Frijlink Ii)-
Jun 27, 2024Bb44A Annexes To Expert Declaration Of Prof. Dr. H.W. Frijlink Ii-
Jun 27, 2024Bb43 Witness Statement Of Dongkyu Kim-
Jun 27, 2024Bb43A Exhibit 1 To Witness Statement Of Dongkyu Kim-
Jun 27, 2024Bb42 Witness Statement Annelies VAN Leeuwen-
Jun 27, 2024Bb41 Witness Statement Bart Buiks-
Jun 27, 2024Bb40 Witness Statement Joel VAN Ruyskensvelde-
Jun 27, 2024Bb39 Witness Statement Taeksang Kwon-
Jun 27, 2024Bb38 Higher Regional Court Dusseldorf Judgment Of (I 2 U 44 12)-
Jun 27, 2024Bb38A English Machine Translation Of Exhibit Bb38-
Jun 27, 2024Acknowledgement Of Lodging-
Jun 14, 2024Procedural Order (Declaration)
Jun 14, 2024Outcome Of The Order-
Jun 7, 2024Receipt-
Jun 7, 2024Exhibit Fbd 45A-
Jun 7, 2024Exhibit Fbd 45-
Jun 7, 2024Exhibit Fbd 44-
Jun 7, 2024Exhibit Fbd 43-
Jun 7, 2024Exhibit Fbd 42-
Jun 7, 2024Exhibit Fbd 41-
Jun 7, 2024Exhibit Fbd 40 (Conf)-
Jun 7, 2024Exhibit Fbd 39 (Conf)-
Jun 7, 2024Exhibit Fbd 38 (Conf)-
Jun 7, 2024Exhibit Fbd 37 (Conf)-
Jun 7, 2024Exhibit Fbd 36 (Conf)-
Jun 7, 2024Exhibit Fbd 36A (Conf)-
Jun 7, 2024Exhibit Fbd 35-
Jun 7, 2024Exhibit Fbd 34-
Jun 7, 2024Application Pursuant To R. 9 Rop Upc-
Jun 7, 2024Application Pursuant To R. 262.2 Rop Upc-
Jun 7, 202424 06 06 Xolair EP248 VS. Celltrion Inc. Reply-
May 16, 2024Summons-
May 16, 2024Procedural Order Oral Hearing
May 16, 2024Panel Appointment-
May 16, 2024Document Technical Reasons
May 14, 2024Objection Upc Celltrion V Novartis (Signed)-
May 14, 2024Bb37 EP1786830B1-
May 14, 2024Bb36 Hernandez Et Al.-
May 14, 2024Bb35 Jp H04 198195-
May 14, 2024Bb35A Jp H04 198195 Translation Of Description-
May 14, 2024Bb34 WO9006764A1-
May 14, 2024Bb33 Wo A2-
May 14, 2024Bb32 EP0025275A2-
May 14, 2024Bb31 Chen Et Al. Pharmaceutical Research VOL. 20 No. 12 P. 1952 60 (Chen)-
May 14, 2024Bb30 CR Ommelin Pharmaceutical Biotechnology Fundamentals And Applications (Second Edition)-
May 14, 2024Bb29 EP1610820B2-
May 14, 2024Bb28 Letter Novartis Regarding Submission Of Patentees 18 July-
May 14, 2024Bb27 Statement Of Defence By Novartis In The Dutch Proceedings 3 April-
May 14, 2024Bb27A English Machine Translation Of Statement Of Defence By Novartis 3 April-
May 14, 2024Bb26O Third Party Observation 24 May-
May 14, 2024Bb26N Notice Examiner 31 January-
May 14, 2024Bb26M Letter Novartis Regarding Third Party Observation 4 October-
May 14, 2024Bb26L Third Party Observation 22 September-
May 14, 2024Bb26K Yadav Et Al. Pharmaceutical Research VOL. 28 P. Submitted By Letter Of Novartis 26 July (Yad-
May 14, 2024Bb26J Liu Et Al. Journal Of Pharmaceutical Sciences VOL. 94 P. Submitted By Letter Of Novartis 26 July-
May 14, 2024Bb26I Tomar Et Al. Journal Of The Taylor Francis Group VOL. 9 P. 476 489 Submitted By Letter Of Novartis 26 July-
May 14, 2024Bb26H Adjusted Claims 1 3 By Letter Of Novartis 26 July-
May 14, 2024Bb26G Letter Novartis Regarding The Adjustment Of The Claims 26 July-
May 14, 2024Bb26F European Search Report 31 May-
May 14, 2024Bb26E European Search Opinion 10 June-
May 14, 2024Bb26D Letter Novartis On Submission Of Claims 1 21 3 November-
May 14, 2024Bb26C Claims 1 21 Submitted By Letter Of Novartis 3 November-
May 14, 2024Bb26B Letter Epo To Remedy Deficiencies (Submission Of Claims) 28 October-
May 14, 2024Bb26A International Search Report 12 April-
May 14, 2024Bb25 Decision Of The Board Of Appeal Epo On EP6365May-
May 14, 2024Bb24 EP4108259A1-
May 14, 2024Bb23 EP4104859A1-
May 14, 2024Bb22 Technical Primer For The Patent-
May 14, 2024Bb21 Expert Declaration Of Prof. Dr. H.W. Frijlink On Arginine(Hcl) (Expert Declaration Of Prof. Frijlink I)-
May 14, 2024Bb21B Annexes To The Expert Declaration Of Prof. Dr. H.W. Frijlink-
May 14, 2024Bb21A Cv Of Prof. Dr. H.W. Frijlink-
May 14, 2024Bb20 EP2116265B1-
May 13, 2024Order Tqj
May 13, 2024Consent To Allocation Of Technically Qualified Judge-
May 10, 2024Consent To The Appointment Of A Tqj-
May 2, 2024Repeated Upload Of Order 10 April-
May 2, 2024Pre Order Tqj-
Apr 23, 2024Date Of A Possible Oral Hearing
Apr 18, 2024Service To Celltrion Inc.-
Apr 18, 2024Confirmation Of Notification Of Appointment-
Apr 18, 2024Acknowledgement Of Access To Case-
Apr 12, 2024Letter For Service-
Apr 11, 2024Panel Appointment-
Apr 10, 2024Template Order-
Apr 10, 2024R. 207.8 Order
Apr 10, 2024Panel Appointment-
Apr 10, 2024Formal Checks Notification Of Positive Outcome-
Apr 10, 2024Application For Measures Receipt-
Apr 9, 2024Receipt-
Apr 9, 2024Exhibit Fbd 9-
Apr 9, 2024Exhibit Fbd 8-
Apr 9, 2024Exhibit Fbd 7-
Apr 9, 2024Exhibit Fbd 6-
Apr 9, 2024Exhibit Fbd 5 (Confidential)-
Apr 9, 2024Exhibit Fbd 4-
Apr 9, 2024Exhibit Fbd 33-
Apr 9, 2024Exhibit Fbd 32-
Apr 9, 2024Exhibit Fbd 31-
Apr 9, 2024Exhibit Fbd 30-
Apr 9, 2024Exhibit Fbd 3-
Apr 9, 2024Exhibit Fbd 29-
Apr 9, 2024Exhibit Fbd 28-
Apr 9, 2024Exhibit Fbd 27-
Apr 9, 2024Exhibit Fbd 26-
Apr 9, 2024Exhibit Fbd 25-
Apr 9, 2024Exhibit Fbd 24-
Apr 9, 2024Exhibit Fbd 23-
Apr 9, 2024Exhibit Fbd 22-
Apr 9, 2024Exhibit Fbd 21 1-
Apr 9, 2024Exhibit Fbd 21-
Apr 9, 2024Exhibit Fbd 20-
Apr 9, 2024Exhibit Fbd 2-
Apr 9, 2024Exhibit Fbd 19-
Apr 9, 2024Exhibit Fbd 18-
Apr 9, 2024Exhibit Fbd 17-
Apr 9, 2024Exhibit Fbd 16-
Apr 9, 2024Exhibit Fbd 15-
Apr 9, 2024Exhibit Fbd 14-
Apr 9, 2024Exhibit Fbd 13-
Apr 9, 2024Exhibit Fbd 12-
Apr 9, 2024Exhibit Fbd 11-
Apr 9, 2024Exhibit Fbd 10-
Apr 9, 2024Exhibit Fbd 1-
Apr 9, 2024Application To Request Confidentiality From The Public (Rop262.2)-
Apr 9, 2024Application For Provisional Measures-
Apr 9, 2024Application For Measures Acknowledgement-
Mar 27, 2025Case Closure Formal Check-
Sep 6, 2024Measures Decisionoutcome Notification-
Sep 6, 2024Headnote And Keywords-
Sep 6, 2024Final Order On Pi Application
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S04-
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S03-
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S02-
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S01-
Sep 3, 2024Submission Of Epo Preliminary Opinion-
Sep 3, 2024Receipt-
Sep 3, 2024Exhibit Fbd 46-
Jul 24, 2024Time Limits For Parties' Oral Submissions
Jun 27, 2024Rejoinder Upc Celltrion V Novartis (Signed)-
Jun 27, 2024Bb49 Expert Declaration Dr. L. De Leede Of 26 June-
Jun 27, 2024Bb49B Annexes To Expert Declaration Dr. L. De Leede Of 26 June-
Jun 27, 2024Bb49A Cv Of Dr. L. De Leede-
Jun 27, 2024Bb48 Notice From The Epo Regarding Accelerated Proceedings Of 17 June-
Jun 27, 2024Bb47 Presta Et Al J Immunol 1993 VOL 151 No 5 P 2623 2632-
Jun 27, 2024Bb46 Cacia Et Al Biochemistry 1996 VOL 35 No 6 P 1897 1903-
Jun 27, 2024Bb45 Expert Declaration Prof. Dr. T. Dingermann Of 26 June-
Jun 27, 2024Bb45B Annexes To Expert Declaration Of Prof. Dr. T. Dingermann-
Jun 27, 2024Bb45A Cv Of Prof. Dr. T. Dingermann-
Jun 27, 2024Bb44 Expert Declaration Prof. Dr. H.W. Frijlink Of 26 June (Expert Declaration Of Prof. Dr. H.W. Frijlink Ii)-
Jun 27, 2024Bb44A Annexes To Expert Declaration Of Prof. Dr. H.W. Frijlink Ii-
Jun 27, 2024Bb43 Witness Statement Of Dongkyu Kim-
Jun 27, 2024Bb43A Exhibit 1 To Witness Statement Of Dongkyu Kim-
Jun 27, 2024Bb42 Witness Statement Annelies VAN Leeuwen-
Jun 27, 2024Bb41 Witness Statement Bart Buiks-
Jun 27, 2024Bb40 Witness Statement Joel VAN Ruyskensvelde-
Jun 27, 2024Bb39 Witness Statement Taeksang Kwon-
Jun 27, 2024Bb38 Higher Regional Court Dusseldorf Judgment Of (I 2 U 44 12)-
Jun 27, 2024Bb38A English Machine Translation Of Exhibit Bb38-
Jun 27, 2024Acknowledgement Of Lodging-
Jun 14, 2024Procedural Order (Declaration)
Jun 14, 2024Outcome Of The Order-
Jun 7, 2024Receipt-
Jun 7, 2024Exhibit Fbd 45A-
Jun 7, 2024Exhibit Fbd 45-
Jun 7, 2024Exhibit Fbd 44-
Jun 7, 2024Exhibit Fbd 43-
Jun 7, 2024Exhibit Fbd 42-
Jun 7, 2024Exhibit Fbd 41-
Jun 7, 2024Exhibit Fbd 40 (Conf)-
Jun 7, 2024Exhibit Fbd 39 (Conf)-
Jun 7, 2024Exhibit Fbd 38 (Conf)-
Jun 7, 2024Exhibit Fbd 37 (Conf)-
Jun 7, 2024Exhibit Fbd 36 (Conf)-
Jun 7, 2024Exhibit Fbd 36A (Conf)-
Jun 7, 2024Exhibit Fbd 35-
Jun 7, 2024Exhibit Fbd 34-
Jun 7, 2024Application Pursuant To R. 9 Rop Upc-
Jun 7, 2024Application Pursuant To R. 262.2 Rop Upc-
Jun 7, 202424 06 06 Xolair EP248 VS. Celltrion Inc. Reply-
May 16, 2024Summons-
May 16, 2024Procedural Order Oral Hearing
May 16, 2024Panel Appointment-
May 16, 2024Document Technical Reasons
May 14, 2024Objection Upc Celltrion V Novartis (Signed)-
May 14, 2024Bb37 EP1786830B1-
May 14, 2024Bb36 Hernandez Et Al.-
May 14, 2024Bb35 Jp H04 198195-
May 14, 2024Bb35A Jp H04 198195 Translation Of Description-
May 14, 2024Bb34 WO9006764A1-
May 14, 2024Bb33 Wo A2-
May 14, 2024Bb32 EP0025275A2-
May 14, 2024Bb31 Chen Et Al. Pharmaceutical Research VOL. 20 No. 12 P. 1952 60 (Chen)-
May 14, 2024Bb30 CR Ommelin Pharmaceutical Biotechnology Fundamentals And Applications (Second Edition)-
May 14, 2024Bb29 EP1610820B2-
May 14, 2024Bb28 Letter Novartis Regarding Submission Of Patentees 18 July-
May 14, 2024Bb27 Statement Of Defence By Novartis In The Dutch Proceedings 3 April-
May 14, 2024Bb27A English Machine Translation Of Statement Of Defence By Novartis 3 April-
May 14, 2024Bb26O Third Party Observation 24 May-
May 14, 2024Bb26N Notice Examiner 31 January-
May 14, 2024Bb26M Letter Novartis Regarding Third Party Observation 4 October-
May 14, 2024Bb26L Third Party Observation 22 September-
May 14, 2024Bb26K Yadav Et Al. Pharmaceutical Research VOL. 28 P. Submitted By Letter Of Novartis 26 July (Yad-
May 14, 2024Bb26J Liu Et Al. Journal Of Pharmaceutical Sciences VOL. 94 P. Submitted By Letter Of Novartis 26 July-
May 14, 2024Bb26I Tomar Et Al. Journal Of The Taylor Francis Group VOL. 9 P. 476 489 Submitted By Letter Of Novartis 26 July-
May 14, 2024Bb26H Adjusted Claims 1 3 By Letter Of Novartis 26 July-
May 14, 2024Bb26G Letter Novartis Regarding The Adjustment Of The Claims 26 July-
May 14, 2024Bb26F European Search Report 31 May-
May 14, 2024Bb26E European Search Opinion 10 June-
May 14, 2024Bb26D Letter Novartis On Submission Of Claims 1 21 3 November-
May 14, 2024Bb26C Claims 1 21 Submitted By Letter Of Novartis 3 November-
May 14, 2024Bb26B Letter Epo To Remedy Deficiencies (Submission Of Claims) 28 October-
May 14, 2024Bb26A International Search Report 12 April-
May 14, 2024Bb25 Decision Of The Board Of Appeal Epo On EP6365May-
May 14, 2024Bb24 EP4108259A1-
May 14, 2024Bb23 EP4104859A1-
May 14, 2024Bb22 Technical Primer For The Patent-
May 14, 2024Bb21 Expert Declaration Of Prof. Dr. H.W. Frijlink On Arginine(Hcl) (Expert Declaration Of Prof. Frijlink I)-
May 14, 2024Bb21B Annexes To The Expert Declaration Of Prof. Dr. H.W. Frijlink-
May 14, 2024Bb21A Cv Of Prof. Dr. H.W. Frijlink-
May 14, 2024Bb20 EP2116265B1-
May 13, 2024Order Tqj
May 13, 2024Consent To Allocation Of Technically Qualified Judge-
May 10, 2024Consent To The Appointment Of A Tqj-
May 2, 2024Repeated Upload Of Order 10 April-
May 2, 2024Pre Order Tqj-
Apr 23, 2024Date Of A Possible Oral Hearing
Apr 18, 2024Service To Celltrion Inc.-
Apr 18, 2024Confirmation Of Notification Of Appointment-
Apr 18, 2024Acknowledgement Of Access To Case-
Apr 12, 2024Letter For Service-
Apr 11, 2024Panel Appointment-
Apr 10, 2024Template Order-
Apr 10, 2024R. 207.8 Order
Apr 10, 2024Panel Appointment-
Apr 10, 2024Formal Checks Notification Of Positive Outcome-
Apr 10, 2024Application For Measures Receipt-
Apr 9, 2024Receipt-
Apr 9, 2024Exhibit Fbd 9-
Apr 9, 2024Exhibit Fbd 8-
Apr 9, 2024Exhibit Fbd 7-
Apr 9, 2024Exhibit Fbd 6-
Apr 9, 2024Exhibit Fbd 5 (Confidential)-
Apr 9, 2024Exhibit Fbd 4-
Apr 9, 2024Exhibit Fbd 33-
Apr 9, 2024Exhibit Fbd 32-
Apr 9, 2024Exhibit Fbd 31-
Apr 9, 2024Exhibit Fbd 30-
Apr 9, 2024Exhibit Fbd 3-
Apr 9, 2024Exhibit Fbd 29-
Apr 9, 2024Exhibit Fbd 28-
Apr 9, 2024Exhibit Fbd 27-
Apr 9, 2024Exhibit Fbd 26-
Apr 9, 2024Exhibit Fbd 25-
Apr 9, 2024Exhibit Fbd 24-
Apr 9, 2024Exhibit Fbd 23-
Apr 9, 2024Exhibit Fbd 22-
Apr 9, 2024Exhibit Fbd 21 1-
Apr 9, 2024Exhibit Fbd 21-
Apr 9, 2024Exhibit Fbd 20-
Apr 9, 2024Exhibit Fbd 2-
Apr 9, 2024Exhibit Fbd 19-
Apr 9, 2024Exhibit Fbd 18-
Apr 9, 2024Exhibit Fbd 17-
Apr 9, 2024Exhibit Fbd 16-
Apr 9, 2024Exhibit Fbd 15-
Apr 9, 2024Exhibit Fbd 14-
Apr 9, 2024Exhibit Fbd 13-
Apr 9, 2024Exhibit Fbd 12-
Apr 9, 2024Exhibit Fbd 11-
Apr 9, 2024Exhibit Fbd 10-
Apr 9, 2024Exhibit Fbd 1-
Apr 9, 2024Application To Request Confidentiality From The Public (Rop262.2)-
Apr 9, 2024Application For Provisional Measures-
Apr 9, 2024Application For Measures Acknowledgement-
Mar 27, 2025Case Closure Formal Check-
Sep 6, 2024Measures Decisionoutcome Notification-
Sep 6, 2024Headnote And Keywords-
Sep 6, 2024Final Order On Pi Application
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S04-
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S03-
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S02-
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S01-
Sep 3, 2024Submission Of Epo Preliminary Opinion-
Sep 3, 2024Receipt-
Sep 3, 2024Exhibit Fbd 46-
Jul 24, 2024Time Limits For Parties' Oral Submissions
Jun 27, 2024Rejoinder Upc Celltrion V Novartis (Signed)-
Jun 27, 2024Bb49 Expert Declaration Dr. L. De Leede Of 26 June-
Jun 27, 2024Bb49B Annexes To Expert Declaration Dr. L. De Leede Of 26 June-
Jun 27, 2024Bb49A Cv Of Dr. L. De Leede-
Jun 27, 2024Bb48 Notice From The Epo Regarding Accelerated Proceedings Of 17 June-
Jun 27, 2024Bb47 Presta Et Al J Immunol 1993 VOL 151 No 5 P 2623 2632-
Jun 27, 2024Bb46 Cacia Et Al Biochemistry 1996 VOL 35 No 6 P 1897 1903-
Jun 27, 2024Bb45 Expert Declaration Prof. Dr. T. Dingermann Of 26 June-
Jun 27, 2024Bb45B Annexes To Expert Declaration Of Prof. Dr. T. Dingermann-
Jun 27, 2024Bb45A Cv Of Prof. Dr. T. Dingermann-
Jun 27, 2024Bb44 Expert Declaration Prof. Dr. H.W. Frijlink Of 26 June (Expert Declaration Of Prof. Dr. H.W. Frijlink Ii)-
Jun 27, 2024Bb44A Annexes To Expert Declaration Of Prof. Dr. H.W. Frijlink Ii-
Jun 27, 2024Bb43 Witness Statement Of Dongkyu Kim-
Jun 27, 2024Bb43A Exhibit 1 To Witness Statement Of Dongkyu Kim-
Jun 27, 2024Bb42 Witness Statement Annelies VAN Leeuwen-
Jun 27, 2024Bb41 Witness Statement Bart Buiks-
Jun 27, 2024Bb40 Witness Statement Joel VAN Ruyskensvelde-
Jun 27, 2024Bb39 Witness Statement Taeksang Kwon-
Jun 27, 2024Bb38 Higher Regional Court Dusseldorf Judgment Of (I 2 U 44 12)-
Jun 27, 2024Bb38A English Machine Translation Of Exhibit Bb38-
Jun 27, 2024Acknowledgement Of Lodging-
Jun 14, 2024Procedural Order (Declaration)
Jun 14, 2024Outcome Of The Order-
Jun 7, 2024Receipt-
Jun 7, 2024Exhibit Fbd 45A-
Jun 7, 2024Exhibit Fbd 45-
Jun 7, 2024Exhibit Fbd 44-
Jun 7, 2024Exhibit Fbd 43-
Jun 7, 2024Exhibit Fbd 42-
Jun 7, 2024Exhibit Fbd 41-
Jun 7, 2024Exhibit Fbd 40 (Conf)-
Jun 7, 2024Exhibit Fbd 39 (Conf)-
Jun 7, 2024Exhibit Fbd 38 (Conf)-
Jun 7, 2024Exhibit Fbd 37 (Conf)-
Jun 7, 2024Exhibit Fbd 36 (Conf)-
Jun 7, 2024Exhibit Fbd 36A (Conf)-
Jun 7, 2024Exhibit Fbd 35-
Jun 7, 2024Exhibit Fbd 34-
Jun 7, 2024Application Pursuant To R. 9 Rop Upc-
Jun 7, 2024Application Pursuant To R. 262.2 Rop Upc-
Jun 7, 202424 06 06 Xolair EP248 VS. Celltrion Inc. Reply-
May 16, 2024Summons-
May 16, 2024Procedural Order Oral Hearing
May 16, 2024Panel Appointment-
May 16, 2024Document Technical Reasons
May 14, 2024Objection Upc Celltrion V Novartis (Signed)-
May 14, 2024Bb37 EP1786830B1-
May 14, 2024Bb36 Hernandez Et Al.-
May 14, 2024Bb35 Jp H04 198195-
May 14, 2024Bb35A Jp H04 198195 Translation Of Description-
May 14, 2024Bb34 WO9006764A1-
May 14, 2024Bb33 Wo A2-
May 14, 2024Bb32 EP0025275A2-
May 14, 2024Bb31 Chen Et Al. Pharmaceutical Research VOL. 20 No. 12 P. 1952 60 (Chen)-
May 14, 2024Bb30 CR Ommelin Pharmaceutical Biotechnology Fundamentals And Applications (Second Edition)-
May 14, 2024Bb29 EP1610820B2-
May 14, 2024Bb28 Letter Novartis Regarding Submission Of Patentees 18 July-
May 14, 2024Bb27 Statement Of Defence By Novartis In The Dutch Proceedings 3 April-
May 14, 2024Bb27A English Machine Translation Of Statement Of Defence By Novartis 3 April-
May 14, 2024Bb26O Third Party Observation 24 May-
May 14, 2024Bb26N Notice Examiner 31 January-
May 14, 2024Bb26M Letter Novartis Regarding Third Party Observation 4 October-
May 14, 2024Bb26L Third Party Observation 22 September-
May 14, 2024Bb26K Yadav Et Al. Pharmaceutical Research VOL. 28 P. Submitted By Letter Of Novartis 26 July (Yad-
May 14, 2024Bb26J Liu Et Al. Journal Of Pharmaceutical Sciences VOL. 94 P. Submitted By Letter Of Novartis 26 July-
May 14, 2024Bb26I Tomar Et Al. Journal Of The Taylor Francis Group VOL. 9 P. 476 489 Submitted By Letter Of Novartis 26 July-
May 14, 2024Bb26H Adjusted Claims 1 3 By Letter Of Novartis 26 July-
May 14, 2024Bb26G Letter Novartis Regarding The Adjustment Of The Claims 26 July-
May 14, 2024Bb26F European Search Report 31 May-
May 14, 2024Bb26E European Search Opinion 10 June-
May 14, 2024Bb26D Letter Novartis On Submission Of Claims 1 21 3 November-
May 14, 2024Bb26C Claims 1 21 Submitted By Letter Of Novartis 3 November-
May 14, 2024Bb26B Letter Epo To Remedy Deficiencies (Submission Of Claims) 28 October-
May 14, 2024Bb26A International Search Report 12 April-
May 14, 2024Bb25 Decision Of The Board Of Appeal Epo On EP6365May-
May 14, 2024Bb24 EP4108259A1-
May 14, 2024Bb23 EP4104859A1-
May 14, 2024Bb22 Technical Primer For The Patent-
May 14, 2024Bb21 Expert Declaration Of Prof. Dr. H.W. Frijlink On Arginine(Hcl) (Expert Declaration Of Prof. Frijlink I)-
May 14, 2024Bb21B Annexes To The Expert Declaration Of Prof. Dr. H.W. Frijlink-
May 14, 2024Bb21A Cv Of Prof. Dr. H.W. Frijlink-
May 14, 2024Bb20 EP2116265B1-
May 13, 2024Order Tqj
May 13, 2024Consent To Allocation Of Technically Qualified Judge-
May 10, 2024Consent To The Appointment Of A Tqj-
May 2, 2024Repeated Upload Of Order 10 April-
May 2, 2024Pre Order Tqj-
Apr 23, 2024Date Of A Possible Oral Hearing
Apr 18, 2024Service To Celltrion Inc.-
Apr 18, 2024Confirmation Of Notification Of Appointment-
Apr 18, 2024Acknowledgement Of Access To Case-
Apr 12, 2024Letter For Service-
Apr 11, 2024Panel Appointment-
Apr 10, 2024Template Order-
Apr 10, 2024R. 207.8 Order
Apr 10, 2024Panel Appointment-
Apr 10, 2024Formal Checks Notification Of Positive Outcome-
Apr 10, 2024Application For Measures Receipt-
Apr 9, 2024Receipt-
Apr 9, 2024Exhibit Fbd 9-
Apr 9, 2024Exhibit Fbd 8-
Apr 9, 2024Exhibit Fbd 7-
Apr 9, 2024Exhibit Fbd 6-
Apr 9, 2024Exhibit Fbd 5 (Confidential)-
Apr 9, 2024Exhibit Fbd 4-
Apr 9, 2024Exhibit Fbd 33-
Apr 9, 2024Exhibit Fbd 32-
Apr 9, 2024Exhibit Fbd 31-
Apr 9, 2024Exhibit Fbd 30-
Apr 9, 2024Exhibit Fbd 3-
Apr 9, 2024Exhibit Fbd 29-
Apr 9, 2024Exhibit Fbd 28-
Apr 9, 2024Exhibit Fbd 27-
Apr 9, 2024Exhibit Fbd 26-
Apr 9, 2024Exhibit Fbd 25-
Apr 9, 2024Exhibit Fbd 24-
Apr 9, 2024Exhibit Fbd 23-
Apr 9, 2024Exhibit Fbd 22-
Apr 9, 2024Exhibit Fbd 21 1-
Apr 9, 2024Exhibit Fbd 21-
Apr 9, 2024Exhibit Fbd 20-
Apr 9, 2024Exhibit Fbd 2-
Apr 9, 2024Exhibit Fbd 19-
Apr 9, 2024Exhibit Fbd 18-
Apr 9, 2024Exhibit Fbd 17-
Apr 9, 2024Exhibit Fbd 16-
Apr 9, 2024Exhibit Fbd 15-
Apr 9, 2024Exhibit Fbd 14-
Apr 9, 2024Exhibit Fbd 13-
Apr 9, 2024Exhibit Fbd 12-
Apr 9, 2024Exhibit Fbd 11-
Apr 9, 2024Exhibit Fbd 10-
Apr 9, 2024Exhibit Fbd 1-
Apr 9, 2024Application To Request Confidentiality From The Public (Rop262.2)-
Apr 9, 2024Application For Provisional Measures-
Apr 9, 2024Application For Measures Acknowledgement-
Mar 27, 2025Case Closure Formal Check-
Sep 6, 2024Measures Decisionoutcome Notification-
Sep 6, 2024Headnote And Keywords-
Sep 6, 2024Final Order On Pi Application
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S04-
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S03-
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S02-
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S01-
Sep 3, 2024Submission Of Epo Preliminary Opinion-
Sep 3, 2024Receipt-
Sep 3, 2024Exhibit Fbd 46-
Jul 24, 2024Time Limits For Parties' Oral Submissions
Jun 27, 2024Rejoinder Upc Celltrion V Novartis (Signed)-
Jun 27, 2024Bb49 Expert Declaration Dr. L. De Leede Of 26 June-
Jun 27, 2024Bb49B Annexes To Expert Declaration Dr. L. De Leede Of 26 June-
Jun 27, 2024Bb49A Cv Of Dr. L. De Leede-
Jun 27, 2024Bb48 Notice From The Epo Regarding Accelerated Proceedings Of 17 June-
Jun 27, 2024Bb47 Presta Et Al J Immunol 1993 VOL 151 No 5 P 2623 2632-
Jun 27, 2024Bb46 Cacia Et Al Biochemistry 1996 VOL 35 No 6 P 1897 1903-
Jun 27, 2024Bb45 Expert Declaration Prof. Dr. T. Dingermann Of 26 June-
Jun 27, 2024Bb45B Annexes To Expert Declaration Of Prof. Dr. T. Dingermann-
Jun 27, 2024Bb45A Cv Of Prof. Dr. T. Dingermann-
Jun 27, 2024Bb44 Expert Declaration Prof. Dr. H.W. Frijlink Of 26 June (Expert Declaration Of Prof. Dr. H.W. Frijlink Ii)-
Jun 27, 2024Bb44A Annexes To Expert Declaration Of Prof. Dr. H.W. Frijlink Ii-
Jun 27, 2024Bb43 Witness Statement Of Dongkyu Kim-
Jun 27, 2024Bb43A Exhibit 1 To Witness Statement Of Dongkyu Kim-
Jun 27, 2024Bb42 Witness Statement Annelies VAN Leeuwen-
Jun 27, 2024Bb41 Witness Statement Bart Buiks-
Jun 27, 2024Bb40 Witness Statement Joel VAN Ruyskensvelde-
Jun 27, 2024Bb39 Witness Statement Taeksang Kwon-
Jun 27, 2024Bb38 Higher Regional Court Dusseldorf Judgment Of (I 2 U 44 12)-
Jun 27, 2024Bb38A English Machine Translation Of Exhibit Bb38-
Jun 27, 2024Acknowledgement Of Lodging-
Jun 14, 2024Procedural Order (Declaration)
Jun 14, 2024Outcome Of The Order-
Jun 7, 2024Receipt-
Jun 7, 2024Exhibit Fbd 45A-
Jun 7, 2024Exhibit Fbd 45-
Jun 7, 2024Exhibit Fbd 44-
Jun 7, 2024Exhibit Fbd 43-
Jun 7, 2024Exhibit Fbd 42-
Jun 7, 2024Exhibit Fbd 41-
Jun 7, 2024Exhibit Fbd 40 (Conf)-
Jun 7, 2024Exhibit Fbd 39 (Conf)-
Jun 7, 2024Exhibit Fbd 38 (Conf)-
Jun 7, 2024Exhibit Fbd 37 (Conf)-
Jun 7, 2024Exhibit Fbd 36 (Conf)-
Jun 7, 2024Exhibit Fbd 36A (Conf)-
Jun 7, 2024Exhibit Fbd 35-
Jun 7, 2024Exhibit Fbd 34-
Jun 7, 2024Application Pursuant To R. 9 Rop Upc-
Jun 7, 2024Application Pursuant To R. 262.2 Rop Upc-
Jun 7, 202424 06 06 Xolair EP248 VS. Celltrion Inc. Reply-
May 16, 2024Summons-
May 16, 2024Procedural Order Oral Hearing
May 16, 2024Panel Appointment-
May 16, 2024Document Technical Reasons
May 14, 2024Objection Upc Celltrion V Novartis (Signed)-
May 14, 2024Bb37 EP1786830B1-
May 14, 2024Bb36 Hernandez Et Al.-
May 14, 2024Bb35 Jp H04 198195-
May 14, 2024Bb35A Jp H04 198195 Translation Of Description-
May 14, 2024Bb34 WO9006764A1-
May 14, 2024Bb33 Wo A2-
May 14, 2024Bb32 EP0025275A2-
May 14, 2024Bb31 Chen Et Al. Pharmaceutical Research VOL. 20 No. 12 P. 1952 60 (Chen)-
May 14, 2024Bb30 CR Ommelin Pharmaceutical Biotechnology Fundamentals And Applications (Second Edition)-
May 14, 2024Bb29 EP1610820B2-
May 14, 2024Bb28 Letter Novartis Regarding Submission Of Patentees 18 July-
May 14, 2024Bb27 Statement Of Defence By Novartis In The Dutch Proceedings 3 April-
May 14, 2024Bb27A English Machine Translation Of Statement Of Defence By Novartis 3 April-
May 14, 2024Bb26O Third Party Observation 24 May-
May 14, 2024Bb26N Notice Examiner 31 January-
May 14, 2024Bb26M Letter Novartis Regarding Third Party Observation 4 October-
May 14, 2024Bb26L Third Party Observation 22 September-
May 14, 2024Bb26K Yadav Et Al. Pharmaceutical Research VOL. 28 P. Submitted By Letter Of Novartis 26 July (Yad-
May 14, 2024Bb26J Liu Et Al. Journal Of Pharmaceutical Sciences VOL. 94 P. Submitted By Letter Of Novartis 26 July-
May 14, 2024Bb26I Tomar Et Al. Journal Of The Taylor Francis Group VOL. 9 P. 476 489 Submitted By Letter Of Novartis 26 July-
May 14, 2024Bb26H Adjusted Claims 1 3 By Letter Of Novartis 26 July-
May 14, 2024Bb26G Letter Novartis Regarding The Adjustment Of The Claims 26 July-
May 14, 2024Bb26F European Search Report 31 May-
May 14, 2024Bb26E European Search Opinion 10 June-
May 14, 2024Bb26D Letter Novartis On Submission Of Claims 1 21 3 November-
May 14, 2024Bb26C Claims 1 21 Submitted By Letter Of Novartis 3 November-
May 14, 2024Bb26B Letter Epo To Remedy Deficiencies (Submission Of Claims) 28 October-
May 14, 2024Bb26A International Search Report 12 April-
May 14, 2024Bb25 Decision Of The Board Of Appeal Epo On EP6365May-
May 14, 2024Bb24 EP4108259A1-
May 14, 2024Bb23 EP4104859A1-
May 14, 2024Bb22 Technical Primer For The Patent-
May 14, 2024Bb21 Expert Declaration Of Prof. Dr. H.W. Frijlink On Arginine(Hcl) (Expert Declaration Of Prof. Frijlink I)-
May 14, 2024Bb21B Annexes To The Expert Declaration Of Prof. Dr. H.W. Frijlink-
May 14, 2024Bb21A Cv Of Prof. Dr. H.W. Frijlink-
May 14, 2024Bb20 EP2116265B1-
May 13, 2024Order Tqj
May 13, 2024Consent To Allocation Of Technically Qualified Judge-
May 10, 2024Consent To The Appointment Of A Tqj-
May 2, 2024Repeated Upload Of Order 10 April-
May 2, 2024Pre Order Tqj-
Apr 23, 2024Date Of A Possible Oral Hearing
Apr 18, 2024Service To Celltrion Inc.-
Apr 18, 2024Confirmation Of Notification Of Appointment-
Apr 18, 2024Acknowledgement Of Access To Case-
Apr 12, 2024Letter For Service-
Apr 11, 2024Panel Appointment-
Apr 10, 2024Template Order-
Apr 10, 2024R. 207.8 Order
Apr 10, 2024Panel Appointment-
Apr 10, 2024Formal Checks Notification Of Positive Outcome-
Apr 10, 2024Application For Measures Receipt-
Apr 9, 2024Receipt-
Apr 9, 2024Exhibit Fbd 9-
Apr 9, 2024Exhibit Fbd 8-
Apr 9, 2024Exhibit Fbd 7-
Apr 9, 2024Exhibit Fbd 6-
Apr 9, 2024Exhibit Fbd 5 (Confidential)-
Apr 9, 2024Exhibit Fbd 4-
Apr 9, 2024Exhibit Fbd 33-
Apr 9, 2024Exhibit Fbd 32-
Apr 9, 2024Exhibit Fbd 31-
Apr 9, 2024Exhibit Fbd 30-
Apr 9, 2024Exhibit Fbd 3-
Apr 9, 2024Exhibit Fbd 29-
Apr 9, 2024Exhibit Fbd 28-
Apr 9, 2024Exhibit Fbd 27-
Apr 9, 2024Exhibit Fbd 26-
Apr 9, 2024Exhibit Fbd 25-
Apr 9, 2024Exhibit Fbd 24-
Apr 9, 2024Exhibit Fbd 23-
Apr 9, 2024Exhibit Fbd 22-
Apr 9, 2024Exhibit Fbd 21 1-
Apr 9, 2024Exhibit Fbd 21-
Apr 9, 2024Exhibit Fbd 20-
Apr 9, 2024Exhibit Fbd 2-
Apr 9, 2024Exhibit Fbd 19-
Apr 9, 2024Exhibit Fbd 18-
Apr 9, 2024Exhibit Fbd 17-
Apr 9, 2024Exhibit Fbd 16-
Apr 9, 2024Exhibit Fbd 15-
Apr 9, 2024Exhibit Fbd 14-
Apr 9, 2024Exhibit Fbd 13-
Apr 9, 2024Exhibit Fbd 12-
Apr 9, 2024Exhibit Fbd 11-
Apr 9, 2024Exhibit Fbd 10-
Apr 9, 2024Exhibit Fbd 1-
Apr 9, 2024Application To Request Confidentiality From The Public (Rop262.2)-
Apr 9, 2024Application For Provisional Measures-
Apr 9, 2024Application For Measures Acknowledgement-
Mar 27, 2025Case Closure Formal Check-
Sep 6, 2024Measures Decisionoutcome Notification-
Sep 6, 2024Headnote And Keywords-
Sep 6, 2024Final Order On Pi Application
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S04-
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S03-
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S02-
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S01-
Sep 3, 2024Submission Of Epo Preliminary Opinion-
Sep 3, 2024Receipt-
Sep 3, 2024Exhibit Fbd 46-
Jul 24, 2024Time Limits For Parties' Oral Submissions
Jun 27, 2024Rejoinder Upc Celltrion V Novartis (Signed)-
Jun 27, 2024Bb49 Expert Declaration Dr. L. De Leede Of 26 June-
Jun 27, 2024Bb49B Annexes To Expert Declaration Dr. L. De Leede Of 26 June-
Jun 27, 2024Bb49A Cv Of Dr. L. De Leede-
Jun 27, 2024Bb48 Notice From The Epo Regarding Accelerated Proceedings Of 17 June-
Jun 27, 2024Bb47 Presta Et Al J Immunol 1993 VOL 151 No 5 P 2623 2632-
Jun 27, 2024Bb46 Cacia Et Al Biochemistry 1996 VOL 35 No 6 P 1897 1903-
Jun 27, 2024Bb45 Expert Declaration Prof. Dr. T. Dingermann Of 26 June-
Jun 27, 2024Bb45B Annexes To Expert Declaration Of Prof. Dr. T. Dingermann-
Jun 27, 2024Bb45A Cv Of Prof. Dr. T. Dingermann-
Jun 27, 2024Bb44 Expert Declaration Prof. Dr. H.W. Frijlink Of 26 June (Expert Declaration Of Prof. Dr. H.W. Frijlink Ii)-
Jun 27, 2024Bb44A Annexes To Expert Declaration Of Prof. Dr. H.W. Frijlink Ii-
Jun 27, 2024Bb43 Witness Statement Of Dongkyu Kim-
Jun 27, 2024Bb43A Exhibit 1 To Witness Statement Of Dongkyu Kim-
Jun 27, 2024Bb42 Witness Statement Annelies VAN Leeuwen-
Jun 27, 2024Bb41 Witness Statement Bart Buiks-
Jun 27, 2024Bb40 Witness Statement Joel VAN Ruyskensvelde-
Jun 27, 2024Bb39 Witness Statement Taeksang Kwon-
Jun 27, 2024Bb38 Higher Regional Court Dusseldorf Judgment Of (I 2 U 44 12)-
Jun 27, 2024Bb38A English Machine Translation Of Exhibit Bb38-
Jun 27, 2024Acknowledgement Of Lodging-
Jun 14, 2024Procedural Order (Declaration)
Jun 14, 2024Outcome Of The Order-
Jun 7, 2024Receipt-
Jun 7, 2024Exhibit Fbd 45A-
Jun 7, 2024Exhibit Fbd 45-
Jun 7, 2024Exhibit Fbd 44-
Jun 7, 2024Exhibit Fbd 43-
Jun 7, 2024Exhibit Fbd 42-
Jun 7, 2024Exhibit Fbd 41-
Jun 7, 2024Exhibit Fbd 40 (Conf)-
Jun 7, 2024Exhibit Fbd 39 (Conf)-
Jun 7, 2024Exhibit Fbd 38 (Conf)-
Jun 7, 2024Exhibit Fbd 37 (Conf)-
Jun 7, 2024Exhibit Fbd 36 (Conf)-
Jun 7, 2024Exhibit Fbd 36A (Conf)-
Jun 7, 2024Exhibit Fbd 35-
Jun 7, 2024Exhibit Fbd 34-
Jun 7, 2024Application Pursuant To R. 9 Rop Upc-
Jun 7, 2024Application Pursuant To R. 262.2 Rop Upc-
Jun 7, 202424 06 06 Xolair EP248 VS. Celltrion Inc. Reply-
May 16, 2024Summons-
May 16, 2024Procedural Order Oral Hearing
May 16, 2024Panel Appointment-
May 16, 2024Document Technical Reasons
May 14, 2024Objection Upc Celltrion V Novartis (Signed)-
May 14, 2024Bb37 EP1786830B1-
May 14, 2024Bb36 Hernandez Et Al.-
May 14, 2024Bb35 Jp H04 198195-
May 14, 2024Bb35A Jp H04 198195 Translation Of Description-
May 14, 2024Bb34 WO9006764A1-
May 14, 2024Bb33 Wo A2-
May 14, 2024Bb32 EP0025275A2-
May 14, 2024Bb31 Chen Et Al. Pharmaceutical Research VOL. 20 No. 12 P. 1952 60 (Chen)-
May 14, 2024Bb30 CR Ommelin Pharmaceutical Biotechnology Fundamentals And Applications (Second Edition)-
May 14, 2024Bb29 EP1610820B2-
May 14, 2024Bb28 Letter Novartis Regarding Submission Of Patentees 18 July-
May 14, 2024Bb27 Statement Of Defence By Novartis In The Dutch Proceedings 3 April-
May 14, 2024Bb27A English Machine Translation Of Statement Of Defence By Novartis 3 April-
May 14, 2024Bb26O Third Party Observation 24 May-
May 14, 2024Bb26N Notice Examiner 31 January-
May 14, 2024Bb26M Letter Novartis Regarding Third Party Observation 4 October-
May 14, 2024Bb26L Third Party Observation 22 September-
May 14, 2024Bb26K Yadav Et Al. Pharmaceutical Research VOL. 28 P. Submitted By Letter Of Novartis 26 July (Yad-
May 14, 2024Bb26J Liu Et Al. Journal Of Pharmaceutical Sciences VOL. 94 P. Submitted By Letter Of Novartis 26 July-
May 14, 2024Bb26I Tomar Et Al. Journal Of The Taylor Francis Group VOL. 9 P. 476 489 Submitted By Letter Of Novartis 26 July-
May 14, 2024Bb26H Adjusted Claims 1 3 By Letter Of Novartis 26 July-
May 14, 2024Bb26G Letter Novartis Regarding The Adjustment Of The Claims 26 July-
May 14, 2024Bb26F European Search Report 31 May-
May 14, 2024Bb26E European Search Opinion 10 June-
May 14, 2024Bb26D Letter Novartis On Submission Of Claims 1 21 3 November-
May 14, 2024Bb26C Claims 1 21 Submitted By Letter Of Novartis 3 November-
May 14, 2024Bb26B Letter Epo To Remedy Deficiencies (Submission Of Claims) 28 October-
May 14, 2024Bb26A International Search Report 12 April-
May 14, 2024Bb25 Decision Of The Board Of Appeal Epo On EP6365May-
May 14, 2024Bb24 EP4108259A1-
May 14, 2024Bb23 EP4104859A1-
May 14, 2024Bb22 Technical Primer For The Patent-
May 14, 2024Bb21 Expert Declaration Of Prof. Dr. H.W. Frijlink On Arginine(Hcl) (Expert Declaration Of Prof. Frijlink I)-
May 14, 2024Bb21B Annexes To The Expert Declaration Of Prof. Dr. H.W. Frijlink-
May 14, 2024Bb21A Cv Of Prof. Dr. H.W. Frijlink-
May 14, 2024Bb20 EP2116265B1-
May 13, 2024Order Tqj
May 13, 2024Consent To Allocation Of Technically Qualified Judge-
May 10, 2024Consent To The Appointment Of A Tqj-
May 2, 2024Repeated Upload Of Order 10 April-
May 2, 2024Pre Order Tqj-
Apr 23, 2024Date Of A Possible Oral Hearing
Apr 18, 2024Service To Celltrion Inc.-
Apr 18, 2024Confirmation Of Notification Of Appointment-
Apr 18, 2024Acknowledgement Of Access To Case-
Apr 12, 2024Letter For Service-
Apr 11, 2024Panel Appointment-
Apr 10, 2024Template Order-
Apr 10, 2024R. 207.8 Order
Apr 10, 2024Panel Appointment-
Apr 10, 2024Formal Checks Notification Of Positive Outcome-
Apr 10, 2024Application For Measures Receipt-
Apr 9, 2024Receipt-
Apr 9, 2024Exhibit Fbd 9-
Apr 9, 2024Exhibit Fbd 8-
Apr 9, 2024Exhibit Fbd 7-
Apr 9, 2024Exhibit Fbd 6-
Apr 9, 2024Exhibit Fbd 5 (Confidential)-
Apr 9, 2024Exhibit Fbd 4-
Apr 9, 2024Exhibit Fbd 33-
Apr 9, 2024Exhibit Fbd 32-
Apr 9, 2024Exhibit Fbd 31-
Apr 9, 2024Exhibit Fbd 30-
Apr 9, 2024Exhibit Fbd 3-
Apr 9, 2024Exhibit Fbd 29-
Apr 9, 2024Exhibit Fbd 28-
Apr 9, 2024Exhibit Fbd 27-
Apr 9, 2024Exhibit Fbd 26-
Apr 9, 2024Exhibit Fbd 25-
Apr 9, 2024Exhibit Fbd 24-
Apr 9, 2024Exhibit Fbd 23-
Apr 9, 2024Exhibit Fbd 22-
Apr 9, 2024Exhibit Fbd 21 1-
Apr 9, 2024Exhibit Fbd 21-
Apr 9, 2024Exhibit Fbd 20-
Apr 9, 2024Exhibit Fbd 2-
Apr 9, 2024Exhibit Fbd 19-
Apr 9, 2024Exhibit Fbd 18-
Apr 9, 2024Exhibit Fbd 17-
Apr 9, 2024Exhibit Fbd 16-
Apr 9, 2024Exhibit Fbd 15-
Apr 9, 2024Exhibit Fbd 14-
Apr 9, 2024Exhibit Fbd 13-
Apr 9, 2024Exhibit Fbd 12-
Apr 9, 2024Exhibit Fbd 11-
Apr 9, 2024Exhibit Fbd 10-
Apr 9, 2024Exhibit Fbd 1-
Apr 9, 2024Application To Request Confidentiality From The Public (Rop262.2)-
Apr 9, 2024Application For Provisional Measures-
Apr 9, 2024Application For Measures Acknowledgement-
Mar 27, 2025Case Closure Formal Check-
Sep 6, 2024Measures Decisionoutcome Notification-
Sep 6, 2024Headnote And Keywords-
Sep 6, 2024Final Order On Pi Application
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S04-
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S03-
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S02-
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S01-
Sep 3, 2024Submission Of Epo Preliminary Opinion-
Sep 3, 2024Receipt-
Sep 3, 2024Exhibit Fbd 46-
Jul 24, 2024Time Limits For Parties' Oral Submissions
Jun 27, 2024Rejoinder Upc Celltrion V Novartis (Signed)-
Jun 27, 2024Bb49 Expert Declaration Dr. L. De Leede Of 26 June-
Jun 27, 2024Bb49B Annexes To Expert Declaration Dr. L. De Leede Of 26 June-
Jun 27, 2024Bb49A Cv Of Dr. L. De Leede-
Jun 27, 2024Bb48 Notice From The Epo Regarding Accelerated Proceedings Of 17 June-
Jun 27, 2024Bb47 Presta Et Al J Immunol 1993 VOL 151 No 5 P 2623 2632-
Jun 27, 2024Bb46 Cacia Et Al Biochemistry 1996 VOL 35 No 6 P 1897 1903-
Jun 27, 2024Bb45 Expert Declaration Prof. Dr. T. Dingermann Of 26 June-
Jun 27, 2024Bb45B Annexes To Expert Declaration Of Prof. Dr. T. Dingermann-
Jun 27, 2024Bb45A Cv Of Prof. Dr. T. Dingermann-
Jun 27, 2024Bb44 Expert Declaration Prof. Dr. H.W. Frijlink Of 26 June (Expert Declaration Of Prof. Dr. H.W. Frijlink Ii)-
Jun 27, 2024Bb44A Annexes To Expert Declaration Of Prof. Dr. H.W. Frijlink Ii-
Jun 27, 2024Bb43 Witness Statement Of Dongkyu Kim-
Jun 27, 2024Bb43A Exhibit 1 To Witness Statement Of Dongkyu Kim-
Jun 27, 2024Bb42 Witness Statement Annelies VAN Leeuwen-
Jun 27, 2024Bb41 Witness Statement Bart Buiks-
Jun 27, 2024Bb40 Witness Statement Joel VAN Ruyskensvelde-
Jun 27, 2024Bb39 Witness Statement Taeksang Kwon-
Jun 27, 2024Bb38 Higher Regional Court Dusseldorf Judgment Of (I 2 U 44 12)-
Jun 27, 2024Bb38A English Machine Translation Of Exhibit Bb38-
Jun 27, 2024Acknowledgement Of Lodging-
Jun 14, 2024Procedural Order (Declaration)
Jun 14, 2024Outcome Of The Order-
Jun 7, 2024Receipt-
Jun 7, 2024Exhibit Fbd 45A-
Jun 7, 2024Exhibit Fbd 45-
Jun 7, 2024Exhibit Fbd 44-
Jun 7, 2024Exhibit Fbd 43-
Jun 7, 2024Exhibit Fbd 42-
Jun 7, 2024Exhibit Fbd 41-
Jun 7, 2024Exhibit Fbd 40 (Conf)-
Jun 7, 2024Exhibit Fbd 39 (Conf)-
Jun 7, 2024Exhibit Fbd 38 (Conf)-
Jun 7, 2024Exhibit Fbd 37 (Conf)-
Jun 7, 2024Exhibit Fbd 36 (Conf)-
Jun 7, 2024Exhibit Fbd 36A (Conf)-
Jun 7, 2024Exhibit Fbd 35-
Jun 7, 2024Exhibit Fbd 34-
Jun 7, 2024Application Pursuant To R. 9 Rop Upc-
Jun 7, 2024Application Pursuant To R. 262.2 Rop Upc-
Jun 7, 202424 06 06 Xolair EP248 VS. Celltrion Inc. Reply-
May 16, 2024Summons-
May 16, 2024Procedural Order Oral Hearing
May 16, 2024Panel Appointment-
May 16, 2024Document Technical Reasons
May 14, 2024Objection Upc Celltrion V Novartis (Signed)-
May 14, 2024Bb37 EP1786830B1-
May 14, 2024Bb36 Hernandez Et Al.-
May 14, 2024Bb35 Jp H04 198195-
May 14, 2024Bb35A Jp H04 198195 Translation Of Description-
May 14, 2024Bb34 WO9006764A1-
May 14, 2024Bb33 Wo A2-
May 14, 2024Bb32 EP0025275A2-
May 14, 2024Bb31 Chen Et Al. Pharmaceutical Research VOL. 20 No. 12 P. 1952 60 (Chen)-
May 14, 2024Bb30 CR Ommelin Pharmaceutical Biotechnology Fundamentals And Applications (Second Edition)-
May 14, 2024Bb29 EP1610820B2-
May 14, 2024Bb28 Letter Novartis Regarding Submission Of Patentees 18 July-
May 14, 2024Bb27 Statement Of Defence By Novartis In The Dutch Proceedings 3 April-
May 14, 2024Bb27A English Machine Translation Of Statement Of Defence By Novartis 3 April-
May 14, 2024Bb26O Third Party Observation 24 May-
May 14, 2024Bb26N Notice Examiner 31 January-
May 14, 2024Bb26M Letter Novartis Regarding Third Party Observation 4 October-
May 14, 2024Bb26L Third Party Observation 22 September-
May 14, 2024Bb26K Yadav Et Al. Pharmaceutical Research VOL. 28 P. Submitted By Letter Of Novartis 26 July (Yad-
May 14, 2024Bb26J Liu Et Al. Journal Of Pharmaceutical Sciences VOL. 94 P. Submitted By Letter Of Novartis 26 July-
May 14, 2024Bb26I Tomar Et Al. Journal Of The Taylor Francis Group VOL. 9 P. 476 489 Submitted By Letter Of Novartis 26 July-
May 14, 2024Bb26H Adjusted Claims 1 3 By Letter Of Novartis 26 July-
May 14, 2024Bb26G Letter Novartis Regarding The Adjustment Of The Claims 26 July-
May 14, 2024Bb26F European Search Report 31 May-
May 14, 2024Bb26E European Search Opinion 10 June-
May 14, 2024Bb26D Letter Novartis On Submission Of Claims 1 21 3 November-
May 14, 2024Bb26C Claims 1 21 Submitted By Letter Of Novartis 3 November-
May 14, 2024Bb26B Letter Epo To Remedy Deficiencies (Submission Of Claims) 28 October-
May 14, 2024Bb26A International Search Report 12 April-
May 14, 2024Bb25 Decision Of The Board Of Appeal Epo On EP6365May-
May 14, 2024Bb24 EP4108259A1-
May 14, 2024Bb23 EP4104859A1-
May 14, 2024Bb22 Technical Primer For The Patent-
May 14, 2024Bb21 Expert Declaration Of Prof. Dr. H.W. Frijlink On Arginine(Hcl) (Expert Declaration Of Prof. Frijlink I)-
May 14, 2024Bb21B Annexes To The Expert Declaration Of Prof. Dr. H.W. Frijlink-
May 14, 2024Bb21A Cv Of Prof. Dr. H.W. Frijlink-
May 14, 2024Bb20 EP2116265B1-
May 13, 2024Order Tqj
May 13, 2024Consent To Allocation Of Technically Qualified Judge-
May 10, 2024Consent To The Appointment Of A Tqj-
May 2, 2024Repeated Upload Of Order 10 April-
May 2, 2024Pre Order Tqj-
Apr 23, 2024Date Of A Possible Oral Hearing
Apr 18, 2024Service To Celltrion Inc.-
Apr 18, 2024Confirmation Of Notification Of Appointment-
Apr 18, 2024Acknowledgement Of Access To Case-
Apr 12, 2024Letter For Service-
Apr 11, 2024Panel Appointment-
Apr 10, 2024Template Order-
Apr 10, 2024R. 207.8 Order
Apr 10, 2024Panel Appointment-
Apr 10, 2024Formal Checks Notification Of Positive Outcome-
Apr 10, 2024Application For Measures Receipt-
Apr 9, 2024Receipt-
Apr 9, 2024Exhibit Fbd 9-
Apr 9, 2024Exhibit Fbd 8-
Apr 9, 2024Exhibit Fbd 7-
Apr 9, 2024Exhibit Fbd 6-
Apr 9, 2024Exhibit Fbd 5 (Confidential)-
Apr 9, 2024Exhibit Fbd 4-
Apr 9, 2024Exhibit Fbd 33-
Apr 9, 2024Exhibit Fbd 32-
Apr 9, 2024Exhibit Fbd 31-
Apr 9, 2024Exhibit Fbd 30-
Apr 9, 2024Exhibit Fbd 3-
Apr 9, 2024Exhibit Fbd 29-
Apr 9, 2024Exhibit Fbd 28-
Apr 9, 2024Exhibit Fbd 27-
Apr 9, 2024Exhibit Fbd 26-
Apr 9, 2024Exhibit Fbd 25-
Apr 9, 2024Exhibit Fbd 24-
Apr 9, 2024Exhibit Fbd 23-
Apr 9, 2024Exhibit Fbd 22-
Apr 9, 2024Exhibit Fbd 21 1-
Apr 9, 2024Exhibit Fbd 21-
Apr 9, 2024Exhibit Fbd 20-
Apr 9, 2024Exhibit Fbd 2-
Apr 9, 2024Exhibit Fbd 19-
Apr 9, 2024Exhibit Fbd 18-
Apr 9, 2024Exhibit Fbd 17-
Apr 9, 2024Exhibit Fbd 16-
Apr 9, 2024Exhibit Fbd 15-
Apr 9, 2024Exhibit Fbd 14-
Apr 9, 2024Exhibit Fbd 13-
Apr 9, 2024Exhibit Fbd 12-
Apr 9, 2024Exhibit Fbd 11-
Apr 9, 2024Exhibit Fbd 10-
Apr 9, 2024Exhibit Fbd 1-
Apr 9, 2024Application To Request Confidentiality From The Public (Rop262.2)-
Apr 9, 2024Application For Provisional Measures-
Apr 9, 2024Application For Measures Acknowledgement-
Mar 27, 2025Case Closure Formal Check-
Sep 6, 2024Measures Decisionoutcome Notification-
Sep 6, 2024Headnote And Keywords-
Sep 6, 2024Final Order On Pi Application
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S04-
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S03-
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S02-
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S01-
Sep 3, 2024Submission Of Epo Preliminary Opinion-
Sep 3, 2024Receipt-
Sep 3, 2024Exhibit Fbd 46-
Jul 24, 2024Time Limits For Parties' Oral Submissions
Jun 27, 2024Rejoinder Upc Celltrion V Novartis (Signed)-
Jun 27, 2024Bb49 Expert Declaration Dr. L. De Leede Of 26 June-
Jun 27, 2024Bb49B Annexes To Expert Declaration Dr. L. De Leede Of 26 June-
Jun 27, 2024Bb49A Cv Of Dr. L. De Leede-
Jun 27, 2024Bb48 Notice From The Epo Regarding Accelerated Proceedings Of 17 June-
Jun 27, 2024Bb47 Presta Et Al J Immunol 1993 VOL 151 No 5 P 2623 2632-
Jun 27, 2024Bb46 Cacia Et Al Biochemistry 1996 VOL 35 No 6 P 1897 1903-
Jun 27, 2024Bb45 Expert Declaration Prof. Dr. T. Dingermann Of 26 June-
Jun 27, 2024Bb45B Annexes To Expert Declaration Of Prof. Dr. T. Dingermann-
Jun 27, 2024Bb45A Cv Of Prof. Dr. T. Dingermann-
Jun 27, 2024Bb44 Expert Declaration Prof. Dr. H.W. Frijlink Of 26 June (Expert Declaration Of Prof. Dr. H.W. Frijlink Ii)-
Jun 27, 2024Bb44A Annexes To Expert Declaration Of Prof. Dr. H.W. Frijlink Ii-
Jun 27, 2024Bb43 Witness Statement Of Dongkyu Kim-
Jun 27, 2024Bb43A Exhibit 1 To Witness Statement Of Dongkyu Kim-
Jun 27, 2024Bb42 Witness Statement Annelies VAN Leeuwen-
Jun 27, 2024Bb41 Witness Statement Bart Buiks-
Jun 27, 2024Bb40 Witness Statement Joel VAN Ruyskensvelde-
Jun 27, 2024Bb39 Witness Statement Taeksang Kwon-
Jun 27, 2024Bb38 Higher Regional Court Dusseldorf Judgment Of (I 2 U 44 12)-
Jun 27, 2024Bb38A English Machine Translation Of Exhibit Bb38-
Jun 27, 2024Acknowledgement Of Lodging-
Jun 14, 2024Procedural Order (Declaration)
Jun 14, 2024Outcome Of The Order-
Jun 7, 2024Receipt-
Jun 7, 2024Exhibit Fbd 45A-
Jun 7, 2024Exhibit Fbd 45-
Jun 7, 2024Exhibit Fbd 44-
Jun 7, 2024Exhibit Fbd 43-
Jun 7, 2024Exhibit Fbd 42-
Jun 7, 2024Exhibit Fbd 41-
Jun 7, 2024Exhibit Fbd 40 (Conf)-
Jun 7, 2024Exhibit Fbd 39 (Conf)-
Jun 7, 2024Exhibit Fbd 38 (Conf)-
Jun 7, 2024Exhibit Fbd 37 (Conf)-
Jun 7, 2024Exhibit Fbd 36 (Conf)-
Jun 7, 2024Exhibit Fbd 36A (Conf)-
Jun 7, 2024Exhibit Fbd 35-
Jun 7, 2024Exhibit Fbd 34-
Jun 7, 2024Application Pursuant To R. 9 Rop Upc-
Jun 7, 2024Application Pursuant To R. 262.2 Rop Upc-
Jun 7, 202424 06 06 Xolair EP248 VS. Celltrion Inc. Reply-
May 16, 2024Summons-
May 16, 2024Procedural Order Oral Hearing
May 16, 2024Panel Appointment-
May 16, 2024Document Technical Reasons
May 14, 2024Objection Upc Celltrion V Novartis (Signed)-
May 14, 2024Bb37 EP1786830B1-
May 14, 2024Bb36 Hernandez Et Al.-
May 14, 2024Bb35 Jp H04 198195-
May 14, 2024Bb35A Jp H04 198195 Translation Of Description-
May 14, 2024Bb34 WO9006764A1-
May 14, 2024Bb33 Wo A2-
May 14, 2024Bb32 EP0025275A2-
May 14, 2024Bb31 Chen Et Al. Pharmaceutical Research VOL. 20 No. 12 P. 1952 60 (Chen)-
May 14, 2024Bb30 CR Ommelin Pharmaceutical Biotechnology Fundamentals And Applications (Second Edition)-
May 14, 2024Bb29 EP1610820B2-
May 14, 2024Bb28 Letter Novartis Regarding Submission Of Patentees 18 July-
May 14, 2024Bb27 Statement Of Defence By Novartis In The Dutch Proceedings 3 April-
May 14, 2024Bb27A English Machine Translation Of Statement Of Defence By Novartis 3 April-
May 14, 2024Bb26O Third Party Observation 24 May-
May 14, 2024Bb26N Notice Examiner 31 January-
May 14, 2024Bb26M Letter Novartis Regarding Third Party Observation 4 October-
May 14, 2024Bb26L Third Party Observation 22 September-
May 14, 2024Bb26K Yadav Et Al. Pharmaceutical Research VOL. 28 P. Submitted By Letter Of Novartis 26 July (Yad-
May 14, 2024Bb26J Liu Et Al. Journal Of Pharmaceutical Sciences VOL. 94 P. Submitted By Letter Of Novartis 26 July-
May 14, 2024Bb26I Tomar Et Al. Journal Of The Taylor Francis Group VOL. 9 P. 476 489 Submitted By Letter Of Novartis 26 July-
May 14, 2024Bb26H Adjusted Claims 1 3 By Letter Of Novartis 26 July-
May 14, 2024Bb26G Letter Novartis Regarding The Adjustment Of The Claims 26 July-
May 14, 2024Bb26F European Search Report 31 May-
May 14, 2024Bb26E European Search Opinion 10 June-
May 14, 2024Bb26D Letter Novartis On Submission Of Claims 1 21 3 November-
May 14, 2024Bb26C Claims 1 21 Submitted By Letter Of Novartis 3 November-
May 14, 2024Bb26B Letter Epo To Remedy Deficiencies (Submission Of Claims) 28 October-
May 14, 2024Bb26A International Search Report 12 April-
May 14, 2024Bb25 Decision Of The Board Of Appeal Epo On EP6365May-
May 14, 2024Bb24 EP4108259A1-
May 14, 2024Bb23 EP4104859A1-
May 14, 2024Bb22 Technical Primer For The Patent-
May 14, 2024Bb21 Expert Declaration Of Prof. Dr. H.W. Frijlink On Arginine(Hcl) (Expert Declaration Of Prof. Frijlink I)-
May 14, 2024Bb21B Annexes To The Expert Declaration Of Prof. Dr. H.W. Frijlink-
May 14, 2024Bb21A Cv Of Prof. Dr. H.W. Frijlink-
May 14, 2024Bb20 EP2116265B1-
May 13, 2024Order Tqj
May 13, 2024Consent To Allocation Of Technically Qualified Judge-
May 10, 2024Consent To The Appointment Of A Tqj-
May 2, 2024Repeated Upload Of Order 10 April-
May 2, 2024Pre Order Tqj-
Apr 23, 2024Date Of A Possible Oral Hearing
Apr 18, 2024Service To Celltrion Inc.-
Apr 18, 2024Confirmation Of Notification Of Appointment-
Apr 18, 2024Acknowledgement Of Access To Case-
Apr 12, 2024Letter For Service-
Apr 11, 2024Panel Appointment-
Apr 10, 2024Template Order-
Apr 10, 2024R. 207.8 Order
Apr 10, 2024Panel Appointment-
Apr 10, 2024Formal Checks Notification Of Positive Outcome-
Apr 10, 2024Application For Measures Receipt-
Apr 9, 2024Receipt-
Apr 9, 2024Exhibit Fbd 9-
Apr 9, 2024Exhibit Fbd 8-
Apr 9, 2024Exhibit Fbd 7-
Apr 9, 2024Exhibit Fbd 6-
Apr 9, 2024Exhibit Fbd 5 (Confidential)-
Apr 9, 2024Exhibit Fbd 4-
Apr 9, 2024Exhibit Fbd 33-
Apr 9, 2024Exhibit Fbd 32-
Apr 9, 2024Exhibit Fbd 31-
Apr 9, 2024Exhibit Fbd 30-
Apr 9, 2024Exhibit Fbd 3-
Apr 9, 2024Exhibit Fbd 29-
Apr 9, 2024Exhibit Fbd 28-
Apr 9, 2024Exhibit Fbd 27-
Apr 9, 2024Exhibit Fbd 26-
Apr 9, 2024Exhibit Fbd 25-
Apr 9, 2024Exhibit Fbd 24-
Apr 9, 2024Exhibit Fbd 23-
Apr 9, 2024Exhibit Fbd 22-
Apr 9, 2024Exhibit Fbd 21 1-
Apr 9, 2024Exhibit Fbd 21-
Apr 9, 2024Exhibit Fbd 20-
Apr 9, 2024Exhibit Fbd 2-
Apr 9, 2024Exhibit Fbd 19-
Apr 9, 2024Exhibit Fbd 18-
Apr 9, 2024Exhibit Fbd 17-
Apr 9, 2024Exhibit Fbd 16-
Apr 9, 2024Exhibit Fbd 15-
Apr 9, 2024Exhibit Fbd 14-
Apr 9, 2024Exhibit Fbd 13-
Apr 9, 2024Exhibit Fbd 12-
Apr 9, 2024Exhibit Fbd 11-
Apr 9, 2024Exhibit Fbd 10-
Apr 9, 2024Exhibit Fbd 1-
Apr 9, 2024Application To Request Confidentiality From The Public (Rop262.2)-
Apr 9, 2024Application For Provisional Measures-
Apr 9, 2024Application For Measures Acknowledgement-
Mar 27, 2025Case Closure Formal Check-
Sep 6, 2024Measures Decisionoutcome Notification-
Sep 6, 2024Headnote And Keywords-
Sep 6, 2024Final Order On Pi Application
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S04-
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S03-
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S02-
Sep 6, 202418551 2024 Oh Dus Loc Upc202407310930Am S01-
Sep 3, 2024Submission Of Epo Preliminary Opinion-
Sep 3, 2024Receipt-
Sep 3, 2024Exhibit Fbd 46-
Jul 24, 2024Time Limits For Parties' Oral Submissions
Jun 27, 2024Rejoinder Upc Celltrion V Novartis (Signed)-
Jun 27, 2024Bb49 Expert Declaration Dr. L. De Leede Of 26 June-
Jun 27, 2024Bb49B Annexes To Expert Declaration Dr. L. De Leede Of 26 June-
Jun 27, 2024Bb49A Cv Of Dr. L. De Leede-
Jun 27, 2024Bb48 Notice From The Epo Regarding Accelerated Proceedings Of 17 June-
Jun 27, 2024Bb47 Presta Et Al J Immunol 1993 VOL 151 No 5 P 2623 2632-
Jun 27, 2024Bb46 Cacia Et Al Biochemistry 1996 VOL 35 No 6 P 1897 1903-
Jun 27, 2024Bb45 Expert Declaration Prof. Dr. T. Dingermann Of 26 June-
Jun 27, 2024Bb45B Annexes To Expert Declaration Of Prof. Dr. T. Dingermann-
Jun 27, 2024Bb45A Cv Of Prof. Dr. T. Dingermann-
Jun 27, 2024Bb44 Expert Declaration Prof. Dr. H.W. Frijlink Of 26 June (Expert Declaration Of Prof. Dr. H.W. Frijlink Ii)-
Jun 27, 2024Bb44A Annexes To Expert Declaration Of Prof. Dr. H.W. Frijlink Ii-
Jun 27, 2024Bb43 Witness Statement Of Dongkyu Kim-
Jun 27, 2024Bb43A Exhibit 1 To Witness Statement Of Dongkyu Kim-
Jun 27, 2024Bb42 Witness Statement Annelies VAN Leeuwen-
Jun 27, 2024Bb41 Witness Statement Bart Buiks-
Jun 27, 2024Bb40 Witness Statement Joel VAN Ruyskensvelde-
Jun 27, 2024Bb39 Witness Statement Taeksang Kwon-
Jun 27, 2024Bb38 Higher Regional Court Dusseldorf Judgment Of (I 2 U 44 12)-
Jun 27, 2024Bb38A English Machine Translation Of Exhibit Bb38-
Jun 27, 2024Acknowledgement Of Lodging-
Jun 14, 2024Procedural Order (Declaration)
Jun 14, 2024Outcome Of The Order-
Jun 7, 2024Receipt-
Jun 7, 2024Exhibit Fbd 45A-
Jun 7, 2024Exhibit Fbd 45-
Jun 7, 2024Exhibit Fbd 44-
Jun 7, 2024Exhibit Fbd 43-
Jun 7, 2024Exhibit Fbd 42-
Jun 7, 2024Exhibit Fbd 41-
Jun 7, 2024Exhibit Fbd 40 (Conf)-
Jun 7, 2024Exhibit Fbd 39 (Conf)-
Jun 7, 2024Exhibit Fbd 38 (Conf)-
Jun 7, 2024Exhibit Fbd 37 (Conf)-
Jun 7, 2024Exhibit Fbd 36 (Conf)-
Jun 7, 2024Exhibit Fbd 36A (Conf)-
Jun 7, 2024Exhibit Fbd 35-
Jun 7, 2024Exhibit Fbd 34-
Jun 7, 2024Application Pursuant To R. 9 Rop Upc-
Jun 7, 2024Application Pursuant To R. 262.2 Rop Upc-
Jun 7, 202424 06 06 Xolair EP248 VS. Celltrion Inc. Reply-
May 16, 2024Summons-
May 16, 2024Procedural Order Oral Hearing
May 16, 2024Panel Appointment-
May 16, 2024Document Technical Reasons
May 14, 2024Objection Upc Celltrion V Novartis (Signed)-
May 14, 2024Bb37 EP1786830B1-
May 14, 2024Bb36 Hernandez Et Al.-
May 14, 2024Bb35 Jp H04 198195-
May 14, 2024Bb35A Jp H04 198195 Translation Of Description-
May 14, 2024Bb34 WO9006764A1-
May 14, 2024Bb33 Wo A2-
May 14, 2024Bb32 EP0025275A2-
May 14, 2024Bb31 Chen Et Al. Pharmaceutical Research VOL. 20 No. 12 P. 1952 60 (Chen)-
May 14, 2024Bb30 CR Ommelin Pharmaceutical Biotechnology Fundamentals And Applications (Second Edition)-
May 14, 2024Bb29 EP1610820B2-
May 14, 2024Bb28 Letter Novartis Regarding Submission Of Patentees 18 July-
May 14, 2024Bb27 Statement Of Defence By Novartis In The Dutch Proceedings 3 April-
May 14, 2024Bb27A English Machine Translation Of Statement Of Defence By Novartis 3 April-
May 14, 2024Bb26O Third Party Observation 24 May-
May 14, 2024Bb26N Notice Examiner 31 January-
May 14, 2024Bb26M Letter Novartis Regarding Third Party Observation 4 October-
May 14, 2024Bb26L Third Party Observation 22 September-
May 14, 2024Bb26K Yadav Et Al. Pharmaceutical Research VOL. 28 P. Submitted By Letter Of Novartis 26 July (Yad-
May 14, 2024Bb26J Liu Et Al. Journal Of Pharmaceutical Sciences VOL. 94 P. Submitted By Letter Of Novartis 26 July-
May 14, 2024Bb26I Tomar Et Al. Journal Of The Taylor Francis Group VOL. 9 P. 476 489 Submitted By Letter Of Novartis 26 July-
May 14, 2024Bb26H Adjusted Claims 1 3 By Letter Of Novartis 26 July-
May 14, 2024Bb26G Letter Novartis Regarding The Adjustment Of The Claims 26 July-
May 14, 2024Bb26F European Search Report 31 May-
May 14, 2024Bb26E European Search Opinion 10 June-
May 14, 2024Bb26D Letter Novartis On Submission Of Claims 1 21 3 November-
May 14, 2024Bb26C Claims 1 21 Submitted By Letter Of Novartis 3 November-
May 14, 2024Bb26B Letter Epo To Remedy Deficiencies (Submission Of Claims) 28 October-
May 14, 2024Bb26A International Search Report 12 April-
May 14, 2024Bb25 Decision Of The Board Of Appeal Epo On EP6365May-
May 14, 2024Bb24 EP4108259A1-
May 14, 2024Bb23 EP4104859A1-
May 14, 2024Bb22 Technical Primer For The Patent-
May 14, 2024Bb21 Expert Declaration Of Prof. Dr. H.W. Frijlink On Arginine(Hcl) (Expert Declaration Of Prof. Frijlink I)-
May 14, 2024Bb21B Annexes To The Expert Declaration Of Prof. Dr. H.W. Frijlink-
May 14, 2024Bb21A Cv Of Prof. Dr. H.W. Frijlink-
May 14, 2024Bb20 EP2116265B1-
May 13, 2024Order Tqj
May 13, 2024Consent To Allocation Of Technically Qualified Judge-
May 10, 2024Consent To The Appointment Of A Tqj-
May 2, 2024Repeated Upload Of Order 10 April-
May 2, 2024Pre Order Tqj-
Apr 23, 2024Date Of A Possible Oral Hearing
Apr 18, 2024Service To Celltrion Inc.-
Apr 18, 2024Confirmation Of Notification Of Appointment-
Apr 18, 2024Acknowledgement Of Access To Case-
Apr 12, 2024Letter For Service-
Apr 11, 2024Panel Appointment-
Apr 10, 2024Template Order-
Apr 10, 2024R. 207.8 Order
Apr 10, 2024Panel Appointment-
Apr 10, 2024Formal Checks Notification Of Positive Outcome-
Apr 10, 2024Application For Measures Receipt-
Apr 9, 2024Receipt-
Apr 9, 2024Exhibit Fbd 9-
Apr 9, 2024Exhibit Fbd 8-
Apr 9, 2024Exhibit Fbd 7-
Apr 9, 2024Exhibit Fbd 6-
Apr 9, 2024Exhibit Fbd 5 (Confidential)-
Apr 9, 2024Exhibit Fbd 4-
Apr 9, 2024Exhibit Fbd 33-
Apr 9, 2024Exhibit Fbd 32-
Apr 9, 2024Exhibit Fbd 31-
Apr 9, 2024Exhibit Fbd 30-
Apr 9, 2024Exhibit Fbd 3-
Apr 9, 2024Exhibit Fbd 29-
Apr 9, 2024Exhibit Fbd 28-
Apr 9, 2024Exhibit Fbd 27-
Apr 9, 2024Exhibit Fbd 26-
Apr 9, 2024Exhibit Fbd 25-
Apr 9, 2024Exhibit Fbd 24-
Apr 9, 2024Exhibit Fbd 23-
Apr 9, 2024Exhibit Fbd 22-
Apr 9, 2024Exhibit Fbd 21 1-
Apr 9, 2024Exhibit Fbd 21-
Apr 9, 2024Exhibit Fbd 20-
Apr 9, 2024Exhibit Fbd 2-
Apr 9, 2024Exhibit Fbd 19-
Apr 9, 2024Exhibit Fbd 18-
Apr 9, 2024Exhibit Fbd 17-
Apr 9, 2024Exhibit Fbd 16-
Apr 9, 2024Exhibit Fbd 15-
Apr 9, 2024Exhibit Fbd 14-
Apr 9, 2024Exhibit Fbd 13-
Apr 9, 2024Exhibit Fbd 12-
Apr 9, 2024Exhibit Fbd 11-
Apr 9, 2024Exhibit Fbd 10-
Apr 9, 2024Exhibit Fbd 1-
Apr 9, 2024Application To Request Confidentiality From The Public (Rop262.2)-
Apr 9, 2024Application For Provisional Measures-
Apr 9, 2024Application For Measures Acknowledgement-

More cases involving EP3805248B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_61187/2024Nov 14, 2024Cohausz & FlorackCelltrion, Genentech, Novartis
APP_61203/2024Nov 14, 2024Cohausz & FlorackCelltrion Healthcare Belgium, Celltrion Healthcare Deutschland, Celltrion Healthcare Finland, Celltrion Healthcare France, Celltrion Healthcare Hungary KFT, Celltrion Healthcare Italy, Celltrion Healthcare Netherlands, Genentech, Novartis
ACT_18492/2024Apr 9, 2024Genentech, NovartisCelltrion Healthcare Belgium, Celltrion Healthcare Deutschland, Celltrion Healthcare Finland, Celltrion Healthcare France, Celltrion Healthcare Hungary KFT, Celltrion Healthcare Italy, Celltrion Healthcare Netherlands

More cases involving Genentech

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
ACT_21478/2025May 6, 2025GenentechOrganon, Organon Heist, Shanghai Henlius Biotech
ACT_21486/2025May 6, 2025GenentechOrganon, Organon Heist, Shanghai Henlius Biotech
UPC_CFI_407/2025May 6, 2025GenentechOrganon, Organon Heist, Shanghai Henlius Biotech

More cases involving Celltrion

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_61187/2024Nov 14, 2024Cohausz & FlorackCelltrion
APP_61203/2024Nov 14, 2024Cohausz & FlorackCelltrion Healthcare Belgium, Celltrion Healthcare Deutschland, Celltrion Healthcare Finland, Celltrion Healthcare France, Celltrion Healthcare Hungary KFT, Celltrion Healthcare Italy, Celltrion Healthcare Netherlands
ORD_43328/2024Jul 24, 2024Genentech, NovartisCelltrion Healthcare Belgium, Celltrion Healthcare Deutschland, Celltrion Healthcare Finland, Celltrion Healthcare France, Celltrion Healthcare Hungary KFT, Celltrion Healthcare Italy, Celltrion Healthcare Netherlands